ConductScience.org, home

Gene · 2012

NIH grants841

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleEMP1 papersNewest fiscal year
P30ES002109MIT Center for Environmental Health Sciences12020
P41EB015909Resource for Quantitative Functional FMRI12020
P50CA058236SPORE in Prostate Cancer12020
P50CA098258MD Anderson Gynecologic SPORE for Uterine Cancers12020
R01AR069653Skin Defense by Dermal Adipocytes12020
R01CA180475KDM6A mutation as an epigenetic driver of multiple myeloma12020
R01CA195732The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy12020
R01CA206210Therapeutic targeting of glutamine metabolism in MDS12020
R01CA207237Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma12020
R01DE007389Novel Role for the P2Y2 Receptor in the Autoimmune Disease Sjogren's Syndrome12020
R01ES019616ASPIRE: Air Pollution: Strategies for Personalized Intervention to Reduce Exposure12020
R01GM083059The role of dynamics in enzyme mechanism and allostery12020
R01GM118530Turning off the molecular switch for pathological self-assembly of FUS12020
R01GM124316Selection and sensing applications of DNAzymes selective for paramagnetic metal ions12020
R01HL044491EPO regulated erythropoiesis12020
R01MH085801Mitochondrial Dysfunction In Schizophrenia12020
R01MH109677Risk genetic variants and cis regulation of gene expression in Bipolar Disorder12020
R01NS093992Targeting aberrant neurogenesis to prevent epilepsy and associated cognitive decline12020
R01NS096148MicroRNAs as critical regulators of remyelination in Multiple Sclerosis12020
R03DK122189Early Life n-3 Fatty Acids Increase Novel Adipogenesis-Regulatory Cells to Condition Adipogenesis in a NR2F2 Dependent Manner12020

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2012/grants?page=18